Market intelligence
PCSAHealthcare
Processa Pharmaceuticals Inc insider activity
In the last 90 days, 6 corporate insiders purchased $134,286 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 4
- 90-day purchase value
- $134,286
- Corporate buyers
- 6
- Latest transaction
- Jun 15, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
